3′-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide

被引:23
作者
Hjelstuen, OK
Tonnesen, HH
Bremer, PO
Verbruggen, AM
机构
[1] Univ Oslo, Dept Pharmaceut, N-0316 Oslo, Norway
[2] Catholic Univ Louvain, Lab Radiopharmaceut Chem, B-3000 Louvain, Belgium
关键词
oligonucleotides; CAPL; 3 '-end labeling; HPLC; MAG3;
D O I
10.1016/S0969-8051(98)00040-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
CARL is a cancer related gene shown to be overexpressed during tumor metastasis formation. A CAPL antisense oligodeoxynucleotide (ODN), GX-I, and a random control ODN (CTRL1) were 3'-conjugated to MAG3, labeled with technetium-99m, purified, and the biodistribution of the radiolabeled conjugates in normal mice was studied. A Tc-99m-MAG3-GX-1 complex of >97% radiochemical purity was obtained and the product was stable for >6 h as determined by reversed phase high performance liquid chromatography (HPLC). Biodistribution studies of the Tc-99m-MAG3-ODNs in groups of four normal mice, sacrificed 5 min and 60 min after injection, demonstrated that the radiolabeled ODNs were distributed in an unspecific manner. The excretion route was mainly urinary. At 60 min, 55.2% of the injected dose of Tc-99m-MAG3-GX-1 and 72.4% of Tc-99m MAG3-CTRL1 was found in the urine. This finding is clearly different from previously reported data on tritiated 20-mer phosphodiester ODNs, as well as the unconjugated Tc-99m-MAG3 chelate, suggesting that Tc-99m-MAG3 coupled to the 3'-end of ODNs has an influence on the biodistribution of the oligo, and possibly has a protective function to enzymatic degradation in vivo. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:651 / 657
页数:7
相关论文
共 19 条
[1]  
BORMANS G, 1995, NUCL MED BIOL, V22, P229
[2]  
DAVIES BR, 1993, ONCOGENE, V8, P999
[3]   ISOLATION AND CHARACTERIZATION OF A GENE SPECIFICALLY EXPRESSED IN DIFFERENT METASTATIC CELLS AND WHOSE DEDUCED GENE-PRODUCT HAS A HIGH DEGREE OF HOMOLOGY TO A CA-2+-BINDING PROTEIN FAMILY [J].
EBRALIDZE, A ;
TULCHINSKY, E ;
GRIGORIAN, M ;
AFANASYEVA, A ;
SENIN, V ;
REVAZOVA, E ;
LUKANIDIN, E .
GENES & DEVELOPMENT, 1989, 3 (07) :1086-1093
[4]   6 S100 GENES ARE CLUSTERED ON HUMAN CHROMOSOME-1Q21 - IDENTIFICATION OF 2 GENES-CODING FOR THE 2 PREVIOUSLY UNREPORTED CALCIUM-BINDING PROTEIN-S100D AND PROTEIN-S100E [J].
ENGELKAMP, D ;
SCHAFER, BW ;
MATTEI, MG ;
ERNE, P ;
HEIZMANN, CW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6547-6551
[5]  
HEROLD M, 1991, PUBLICATION HPLC, V6, P1
[6]  
HNATOWICH DJ, 1995, J NUCL MED, V36, P2306
[7]  
Maelandsmo GM, 1996, CANCER RES, V56, P5490
[8]   DEVELOPMENT OF ANTISENSE THERAPEUTICS - IMPLICATIONS FOR CANCER GENE-THERAPY [J].
MILLIGAN, JF ;
JONES, RJ ;
FROEHLER, BC ;
MATTEUCCI, MD .
GENE THERAPY FOR NEOPLASTIC DISEASES, 1994, 716 :228-241
[9]   CURRENT CONCEPTS IN ANTISENSE DRUG DESIGN [J].
MILLIGAN, JF ;
MATTEUCCI, MD ;
MARTIN, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (14) :1923-1937
[10]   EXPRESSION OF CA2+-BINDING PROTEINS OF THE S100 FAMILY IN MALIGNANT HUMAN BREAST-CANCER CELL-LINES AND BIOPSY SAMPLES [J].
PEDROCCHI, M ;
SCHAFER, BW ;
MUELLER, H ;
EPPENBERGER, U ;
HEIZMANN, CW .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (05) :684-690